Literature DB >> 8844384

Resource management of cataract patients: can visual rehabilitation be achieved in three visits?

A Ionides1, C Claoué.   

Abstract

PURPOSE: To assess the feasibility and acceptability of reduced postoperative follow-up after phacoemulsification using a scleral tunnel technique.
SETTING: Cataract service of a large free-standing eye hospital in a capital city.
METHODS: In this pilot study, patients with age-related cataract requiring surgery were prospectively recruited to a standardized management protocol, the three-episode model, with assessment by an independent observer. Main outcome measures were number of postoperative visits, patient satisfaction, and refractive error at 2 and 6 weeks postoperatively.
RESULTS: Almost 90% of patients could be managed within this model of care. Patient satisfaction was high; no patient requested further hospital visits. Mean change in refractive error between 2 and 6 weeks was 0.34 diopters (D), with a modal value of 0 D. Patients were able to obtain spectacles 2 weeks postoperatively because little change in refraction occurs over the next month.
CONCLUSION: The three-episode model for the management of patients with cataract could result in significant financial savings. Such savings could be used to treat patients with cataract who otherwise would not have treatment or would have their surgery delayed.

Entities:  

Mesh:

Year:  1996        PMID: 8844384     DOI: 10.1016/s0886-3350(96)80309-9

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  [Analysis of optical parameters after cataract surgery and implantation of foldable lens].

Authors:  B Falkenberg; A Kutschan; W Wiegand
Journal:  Ophthalmologe       Date:  2005-06       Impact factor: 1.059

2.  Phacoemulsification versus extracapsular extraction: governmental costs.

Authors:  Newton Kara; Maysa Godoy Gomes Mazurek Sirtoli; Marcony Rodrigues Santhiago; Tais Renata Ribeira Parede; Rodrigo França de Espíndola; Regina de Souza Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.